Clinical Trial Update: Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in Iran is evaluating generic sofosbuvir/ledipasvir for hepatitis C, with no current status or results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sofosbuvir/Ledipasvir (sofosbuvir/ledipasvir)

Snippet

Sponsor: Iran Hepatitis Network | Conditions: Hepatitis C | Phase 3 | Status: UNKNOWN